Company Profile
Corporate Philosophy
Contributing to human health and welfare through the development of innovative drugs.
Contributing to the vitalization of the life science and industry in Japan.
With a venture spirit, challenging new things and open up an era.

Origin of the Company Name
The word “Transfer” in LTT (Life science and Transfer Technology) means “drug delivery,” but it also expresses our wish to be a bridge to deliver drugs created by university-based bio-ventures to the medical field as soon as possible.
LTT Bio-Pharma was established in January 2003 by LTT Laboratories, a pioneer university-launched venture company, through a corporate spin-off to further strengthen its pharmaceutical-related business division.
Company Profile
Name | LTT Bio-Pharma Co., Ltd. |
---|---|
Location |
Head Office Shonan Research Center |
Established | January 2003 (The predecessor of LTT Research Institute was established in April 1988.) |
Board of Directors | Chairman, President and Chief Executive Officer: Tohru Mizushima Vice Chairman of the Board: Ping Tse Director: Tsuchio Otani Director: (General Manager, Shonan Research Center) Koichiro Fukuda Director: Hayato Tanji Director: Mitsuko Takenaga Director: Theresa Tse Director: Yanping Zhao Director: Bofeng Hou Auditor: Toshiyuki Takami, |
Capital | 100 million yen |
Status of Shares | Total number of authorized shares 260,000 shares Total number of shares issued 131,868 Administrator of shareholders’ register I.R. Japan Inc. Contact address: 2-5, Kasumigaseki 3-chome, Chiyoda-ku, Tokyo 100-6026, Japan I.R. Japan, Inc. Stock Transfer Agency Services Department (Inquiry) 0120-975-960 |
Line of Business | Research and development of pharmaceuticals, medical devices and equipment |
Number of employees | 32 (including directors, part-time employees, etc.) *As of March 2023 |
Correspondent Banks |
Sumitomo Mitsui Banking Corporation MUFG Bank, Ltd. |
Access
Access to Head Office
〒105-0013
2-3-8, Hamamatsu-cho, Minato-ku, Tokyo
WTC annex 7th floor
2 minutes walk from JR Hamamatsucho Station
3 minutes walk from Daimon Station on the Toei Transportation

Access to Shonan Research Center
〒251-8555
2-26-1 Muraoka Higashi, Fujisawa City, Kanagawa Prefecture
Shonan Health Innovation Park B33M-1110
10 minutes drive from JR Fujisawa Station
10 minutes drive from JR Ofuna Station

Organization Chart

Corporate Governance Structure

Capital and Business Alliance Companies

Beijing Tide Pharmaceutical Co., Ltd.
Beijing, ChinaBeijing Tide Pharmaceutical Co., Ltd. was established in 1995 as a joint venture with China-Japan Friendship Hospital (Beijing, China), a Chinese government-affiliated hospital. It manufactures and sells a number of pharmaceutical products, including a lipo-PGE1 preparation developed with technical support from our company and TAISHO PHARMACEUTICAL HOLDINGS CO., LTD. We are engaged in joint research and development of many products such as PC-SOD.

Sino Biopharmaceutical Co., Ltd.
Hong KongIt is a holding company with many pharmaceutical companies under its umbrella (it is one of the largest pharmaceutical groups in China) and is listed on the Hong Kong market. Beijing Tide Pharmaceutical Co., Ltd. is one of its subsidiaries. We are in charge of licensing and investment as the contact point of Sino Biopharmaceutical Co., Ltd. for Japanese companies.
Contract Research at Universities
Koriyama-shi,
Fukushima-ken
Nihon University
Okayama-shi,
Okayama-ken
Shujitsu University
Nishitokyo-shi,
Tokyo-to